Advertisement
Canada markets closed
  • S&P/TSX

    22,259.16
    -31.46 (-0.14%)
     
  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     
  • DOW

    39,056.39
    +172.13 (+0.44%)
     
  • CAD/USD

    0.7286
    -0.0002 (-0.03%)
     
  • CRUDE OIL

    79.30
    +0.31 (+0.39%)
     
  • Bitcoin CAD

    84,450.74
    -1,567.73 (-1.82%)
     
  • CMC Crypto 200

    1,310.71
    +16.04 (+1.24%)
     
  • GOLD FUTURES

    2,315.80
    -6.50 (-0.28%)
     
  • RUSSELL 2000

    2,055.14
    -9.51 (-0.46%)
     
  • 10-Yr Bond

    4.4920
    +0.0290 (+0.65%)
     
  • NASDAQ futures

    18,167.75
    -18.75 (-0.10%)
     
  • VOLATILITY

    13.00
    -0.23 (-1.74%)
     
  • FTSE

    8,354.05
    +40.38 (+0.49%)
     
  • NIKKEI 225

    38,354.51
    +152.14 (+0.40%)
     
  • CAD/EUR

    0.6776
    0.0000 (0.00%)
     

Regeneron’s Stock Still Has Room To Run

Regeneron Pharmaceutical shares have risen more than 2,400% over the past five years. Healthcare analyst Kristine Harjes shares why she believes a strong pipeline of drugs is just one reason the stock still has room to run.